Aigh Capital Management LLC Transcode Therapeutics, Inc. Transaction History

Aigh Capital Management LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 12, 2022	BUY	$1.2 - $3.03 $1.55 Million - $3.91 Million	1,289,000 New	1,289,000 $1.62 Million
Q1 2022 May 12, 2022	SELL	$2.03 - $3.01 $2.58 Million - $3.82 Million	-1,270,600 Closed	0 $0
Q4 2021 Feb 10, 2022	BUY	$2.42 - $3.41 $242 - $341	100 Added 0.01%	1,270,600 $3.23 Million
Q3 2021 Nov 12, 2021	BUY	$2.37 - $6.45 $3.01 Million - $8.19 Million	1,270,500 New	1,270,500 $3.8 Million

6.5K

Ticker RNAZ
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 12,977,200
Market Cap $5.97M
Description
TransCode Therapeutics, Inc., a biopharmaceutical company, engages in the development and commercialization of drugs and diagnostics for treating and identifying metastatic disease. Its lead therapeutic candidate, TTX-MC138, is a preclinical stage product for the treatment of metastatic cancer. The company's products in preclinical programs incl...

Get notified when there are updates to the investment portfolio of Aigh Capital Management LLC, based on Form 13F filings with the SEC.

Stay updated on Aigh Capital Management LLC with notifications on news.